2 weeks Ago By ABMN Staff
Sei Investments Co. boosted its position in Phreesia, Inc. ( NYSE:PHR – Free Report ) by 8.
4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 196,815 shares of the company’s stock after buying an additional 15,241 shares during the period. Sei Investments Co.
owned approximately 0.34% of Phreesia worth $4,952,000 as of its most recent SEC filing. Several other institutional investors also recently bought and sold shares of the company.
Nicholas Company Inc. acquired a new position in shares of Phreesia during the fourth quarter worth about $2,452,000. State Street Corp boosted its holdings in Phreesia by 7.
1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares in the last quarter. Geode Capital Management LLC increased its position in Phreesia by 4.
7% during the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after purchasing an additional 55,934 shares during the period. Charles Schwab Investment Management Inc.
raised its stake in shares of Phreesia by 10.3% during the 4th quarter. Charles Schwab Investment Management Inc.
now owns 493,448 shares of the company’s stock worth $12,415,000 after buying an additional 46,209 shares in the last quarter. Finally, Barclays PLC lifted its holdings in shares of Phreesia by 83.6% in the 3rd quarter.
Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after buying an additional 43,225 shares during the period. 92.10% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets A number of equities research analysts have commented on the company. Truist Financial boosted their target price on shares of Phreesia from $31.00 to $34.
00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. KeyCorp boosted their price objective on shares of Phreesia from $28.00 to $30.
00 and gave the stock an “overweight” rating in a report on Wednesday, January 8th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their target price for the company from $24.00 to $32.
00 in a report on Wednesday, January 8th. Robert W. Baird decreased their price target on Phreesia from $34.
00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $30.
00 price objective on shares of Phreesia in a research note on Tuesday, December 10th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $31.
33. Insider Transactions at Phreesia In other news, CFO Balaji Gandhi sold 1,827 shares of the company’s stock in a transaction dated Wednesday, March 26th. The shares were sold at an average price of $27.
46, for a total transaction of $50,169.42. Following the completion of the transaction, the chief financial officer now owns 103,591 shares of the company’s stock, valued at $2,844,608.
86. This represents a 1.73 % decrease in their position.
The transaction was disclosed in a legal filing with the SEC, which is available through this link . Also, General Counsel Allison C. Hoffman sold 3,982 shares of the firm’s stock in a transaction that occurred on Monday, January 6th.
The stock was sold at an average price of $26.61, for a total transaction of $105,961.02.
Following the completion of the sale, the general counsel now directly owns 159,137 shares in the company, valued at $4,234,635.57. This represents a 2.
44 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Insiders sold a total of 164,269 shares of company stock worth $4,661,469 over the last ninety days.
5.80% of the stock is currently owned by corporate insiders. Phreesia Stock Down 0.
4 % Shares of NYSE:PHR opened at $25.46 on Wednesday. The company has a quick ratio of 1.
74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.
The company has a market capitalization of $1.50 billion, a P/E ratio of -17.32 and a beta of 1.
03. Phreesia, Inc. has a 52-week low of $17.
07 and a 52-week high of $30.53. The stock’s fifty day simple moving average is $27.
31 and its 200-day simple moving average is $24.21. Phreesia Profile ( Free Report ) Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. Recommended Stories Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc.
( NYSE:PHR – Free Report ). Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter .
.
